In suspected tumor lysis syndrome, which IV fluid strategy is anticipated to support renal excretion of metabolites?

• A. D5 .45% NS with potassium at maintenance rate of infusion
• B. D5 .45% NS at twice maintenance rate of infusion
• C. D5 .45% NS with phosphorus at maintenance rate of infusion
• D. D5 .45% NS with potassium at twice maintenance rate of infusion

Answer: (B)

Aggressive IV hydration to maximize renal clearance of TLS metabolites is the main idea. When tumor cells lyse, potassium, phosphate, and uric acid flood the blood. The kidneys can excrete these more effectively if urine flow is high, so you want a fluid strategy that expands intravascular volume without adding more of the metabolites themselves.

Choosing a regimen at twice maintenance increases total fluid intake, boosting urine production and helping flush out the released potassium and phosphate. Importantly, the infusion should not introduce additional potassium or phosphate, since those substances are already elevated and need to be excreted rather than loaded further. The dextrose component provides calories, but the crucial factor is volume and avoiding extra electrolyte load.

So, the best approach is a high-rate infusion that does not carry potassium or phosphorus, to promote renal excretion of the metabolites.